NeueHealth (NYSE:NEUE) Shares Down 2% - Should You Sell?

Shares of NeueHealth, Inc. (NYSE:NEUE - Get Free Report) dropped 2% during trading on Monday . The stock traded as low as $6.75 and last traded at $6.74. Approximately 2,130 shares were traded during mid-day trading, a decline of 90% from the average daily volume of 20,434 shares. The stock had previously closed at $6.88.

NeueHealth Stock Performance

The firm's 50-day moving average price is $6.66 and its 200 day moving average price is $6.49. The company has a market capitalization of $61.16 million, a price-to-earnings ratio of -0.13 and a beta of 0.53.

NeueHealth (NYSE:NEUE - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The company reported ($1.80) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($2.51) by $0.71. NeueHealth had a negative net margin of 36.28% and a negative return on equity of 6.40%. The business had revenue of $215.79 million for the quarter, compared to analysts' expectations of $249.50 million. As a group, equities research analysts anticipate that NeueHealth, Inc. will post -9.13 earnings per share for the current fiscal year.

Insider Transactions at NeueHealth

In other NeueHealth news, CFO Jay Matushak sold 4,448 shares of the firm's stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $6.74, for a total value of $29,979.52. Following the sale, the chief financial officer now owns 41,592 shares in the company, valued at $280,330.08. This trade represents a 9.66% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CEO George Lawrence Mikan III sold 12,440 shares of the business's stock in a transaction on Friday, March 14th. The stock was sold at an average price of $6.13, for a total transaction of $76,257.20. Following the sale, the chief executive officer now directly owns 249,454 shares in the company, valued at approximately $1,529,153.02. The trade was a 4.75% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 68,762 shares of company stock valued at $471,711. Corporate insiders own 63.30% of the company's stock.

Institutional Investors Weigh In On NeueHealth

Hedge funds have recently modified their holdings of the company. Virtu Financial LLC acquired a new position in NeueHealth in the 4th quarter worth about $76,000. PenderFund Capital Management Ltd. bought a new stake in shares of NeueHealth during the first quarter worth about $197,000. Finally, Northern Trust Corp increased its stake in shares of NeueHealth by 66.8% in the fourth quarter. Northern Trust Corp now owns 32,644 shares of the company's stock valued at $242,000 after buying an additional 13,074 shares during the period. Institutional investors and hedge funds own 63.88% of the company's stock.

NeueHealth Company Profile

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.